ADDYI

searchlight pharma inc🇨🇦 Health Canada

Approval Id: bd7a0d33da22db84
Drug Approval Canada Name: ADDYI
Product Name: ADDYI
Status: Marketed
Status Date: 2022-04-08
Original Market Date: 2018-11-13
Din: 02473550
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:92.00
Atc Original: G02CX02 FLIBANSERIN
Atc Name: g 02 cx 02
Aig Number: 0160010001
Company Name: searchlight pharma inc
Company Address: 1600 Rue Notre Dame Ouest, Suite 312, Montreal, Quebec, Canada, H3J 1M1

FLIBANSERIN

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bd7a0d33da22db84

Type

Standard